These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 18055424

  • 1. The alteration of serum soluble CD40 ligand levels in overt and subclinical hypothyroidism.
    Akinci B, Comlekci A, Yener S, Demir T, Bayraktar F, Yuksel F, Yesil S.
    Hormones (Athens); 2007; 6(4):327-33. PubMed ID: 18055424
    [Abstract] [Full Text] [Related]

  • 2. Levothyroxine treatment restored the decreased circulating fibroblast growth factor 21 levels in patients with hypothyroidism.
    Wang G, Liu J, Yang N, Hu Y, Zhang H, Miao L, Yao Z, Xu Y.
    Eur J Intern Med; 2016 Jun; 31():94-8. PubMed ID: 27085392
    [Abstract] [Full Text] [Related]

  • 3. Replacement therapy with levothyroxine modulates platelet activation in recent-onset post-thyroidectomy subclinical hypothyroidism.
    Desideri G, Bocale R, D'Amore A, Necozione S, Boscherini M, Carnassale G, Barini A, Barini A, Bellantone R, Lombardi CP.
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):896-901. PubMed ID: 28964662
    [Abstract] [Full Text] [Related]

  • 4. Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement.
    Akinci B, Comlekci A, Ali Ozcan M, Demir T, Yener S, Demirkan F, Yuksel F, Yesil S.
    Endocr J; 2007 Feb; 54(1):45-52. PubMed ID: 17090955
    [Abstract] [Full Text] [Related]

  • 5. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
    Ozcan O, Cakir E, Yaman H, Akgul EO, Erturk K, Beyhan Z, Bilgi C, Erbil MK.
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
    [Abstract] [Full Text] [Related]

  • 6. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
    Tzotzas T, Krassas GE, Konstantinidis T, Bougoulia M.
    Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
    [Abstract] [Full Text] [Related]

  • 7. Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment.
    Marchiori RC, Pereira LA, Naujorks AA, Rovaris DL, Meinerz DF, Duarte MM, Rocha JB.
    BMC Endocr Disord; 2015 Jun 23; 15():32. PubMed ID: 26100072
    [Abstract] [Full Text] [Related]

  • 8. Thyroxine replacement therapy and circulating lipid concentrations.
    Franklyn JA, Daykin J, Betteridge J, Hughes EA, Holder R, Jones SR, Sheppard MC.
    Clin Endocrinol (Oxf); 1993 May 23; 38(5):453-9. PubMed ID: 8330440
    [Abstract] [Full Text] [Related]

  • 9. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea.
    Jung CH, Sung KC, Shin HS, Rhee EJ, Lee WY, Kim BS, Kang JH, Kim H, Kim SW, Lee MH, Park JR, Kim SW.
    Korean J Intern Med; 2003 Sep 23; 18(3):146-53. PubMed ID: 14619383
    [Abstract] [Full Text] [Related]

  • 10. Serum creatine kinase levels in overt and subclinical hypothyroidism.
    Hekimsoy Z, Oktem IK.
    Endocr Res; 2005 Sep 23; 31(3):171-5. PubMed ID: 16392619
    [Abstract] [Full Text] [Related]

  • 11. The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people.
    Unek IT, Bayraktar F, Solmaz D, Ellidokuz H, Sisman AR, Yuksel F, Yesil S.
    Clin Med Res; 2010 Jul 23; 8(2):89-95. PubMed ID: 20660932
    [Abstract] [Full Text] [Related]

  • 12. Increased serum chitotriosidase activity following restoration of euthyroidism in patients with subclinical hypothyroidism.
    Erdal M, Sahin M, Saglam K, Hasimi A, Uckaya G, Yarpuz MY, Taslipinar A, Gharib H, Kutlu M.
    Intern Med; 2008 Jul 23; 47(14):1309-14. PubMed ID: 18628578
    [Abstract] [Full Text] [Related]

  • 13. Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism.
    Kebapcilar L, Akinci B, Bayraktar F, Comlekci A, Solak A, Demir T, Yener S, Küme T, Yesil S.
    Med Princ Pract; 2007 Jul 23; 16(6):432-6. PubMed ID: 17917442
    [Abstract] [Full Text] [Related]

  • 14. Men with lower HDL cholesterol levels have significant increment of soluble CD40 ligand and high-sensitivity CRP levels following the cessation of long-term clopidogrel therapy.
    Obradovic S, Djukanovic N, Todorovic Z, Markovic I, Zamaklar-Trifunovic D, Protic D, Ostojic M.
    J Atheroscler Thromb; 2015 Jul 23; 22(3):284-92. PubMed ID: 25273829
    [Abstract] [Full Text] [Related]

  • 15. Effect of levothyroxine replacement therapy on paraoxonase-1 and carotid intima-media thickness in subclinical hypothyroidism.
    Kebapcilar L, Comlekci A, Tuncel P, Solak A, Secil M, Gencel O, Sahin M, Sari I, Yesil S.
    Med Sci Monit; 2010 Jan 23; 16(1):CR41-7. PubMed ID: 20037493
    [Abstract] [Full Text] [Related]

  • 16. Regression of the increased common carotid artery-intima media thickness in subclinical hypothyroidism after thyroid hormone replacement.
    Kim SK, Kim SH, Park KS, Park SW, Cho YW.
    Endocr J; 2009 Jan 23; 56(6):753-8. PubMed ID: 19506325
    [Abstract] [Full Text] [Related]

  • 17. Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy.
    Yildirimkaya M, Ozata M, Yilmaz K, Kilinç C, Gündoğan MA, Kutluay T.
    Endocr J; 1996 Dec 23; 43(6):731-6. PubMed ID: 9075615
    [Abstract] [Full Text] [Related]

  • 18. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sänger E, Engel G, Hamm AO, Nauck M, Meng W.
    Clin Endocrinol (Oxf); 2004 Jun 23; 60(6):750-7. PubMed ID: 15163340
    [Abstract] [Full Text] [Related]

  • 19. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis.
    Tagami T, Tamanaha T, Shimazu S, Honda K, Nanba K, Nomura H, Yoriko SU, Usui T, Shimatsu A, Naruse M.
    Endocr J; 2010 Jun 23; 57(3):253-8. PubMed ID: 20032565
    [Abstract] [Full Text] [Related]

  • 20. Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified.
    Bogner U, Arntz HR, Peters H, Schleusener H.
    Acta Endocrinol (Copenh); 1993 Mar 23; 128(3):202-6. PubMed ID: 8480467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.